- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
BB Biotech AG (BIONn)
Track today's live BB Biotech (BIONn) share price, performance and key data on this page with our current Xetra:BIONn stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the BB Biotech share price on the Xetra exchange. Use the dropdown to switch exchange for the BIONn share price, head to our technical summary section, which provides analysis on BB Biotech share price buy/sell indicators using real-time data (or discuss the BB Biotech (BIONn) stock price today with other investors in the BB Biotech ETR share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ETR:BIONn share price (ISIN: CH0038389992) to enhance your trading decisions with our free investment tools and resources.
What Is the BB Biotech AG Share Price Today?
The BB Biotech share price today is 55.800.
What Is the Stock Symbol for BB Biotech AG
The stock symbol (or 'ticker') for BB Biotech AG is "BIONn."
What Stock Exchange Does BB Biotech AG Trade On?
BB Biotech AG is listed and trades on the Xetra stock exchange.
Is BB Biotech AG a Good Stock to Buy?
Determining whether BB Biotech (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ETR:BIONn share price (ISIN: CH0038389992) to enhance your trading decisions with our free investment tools and resources.
What Is the BB Biotech AG Share Price Today?
The BB Biotech share price today is 55.800.
What Is the Stock Symbol for BB Biotech AG
The stock symbol (or 'ticker') for BB Biotech AG is "BIONn."
What Stock Exchange Does BB Biotech AG Trade On?
BB Biotech AG is listed and trades on the Xetra stock exchange.
Is BB Biotech AG a Good Stock to Buy?
Determining whether BB Biotech (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
55.800
+0.300(+0.54%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
55.600
55.800
52 wk Range
37.650
60.800
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
55.60055.800
52 wk Range
37.65060.800
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.48%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.48%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BIONn Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
BB Biotech AG Earnings Call Summary for Q2/2026
- BB Biotech's portfolio outperformed the biotech sector index in Q2 2025, led by Revolution Medicines, Oruka, and Relay Therapeutics gains.
- Investment pace accelerated to 10+ new positions per quarter versus one to two historically as firm transitions to AI-driven operating model.
- Company expects to complete proprietary AI operating system in 2025, integrating all investment and research functions into unified platform.
- Stock rose 1.5% to $54.3, trading near 52-week high of $56.3; management cited biotech sector re-acceleration after Q1 pause.
- Eight portfolio acquisitions in past two years represent 20% of all deals in firm's 32-year history; no EPS or revenue guidance provided.
Last Updated: 24/07/2026, 12:42
Read Full TranscriptEarnings
Latest Release
27/07/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare BIONn to Peers and Sector
Metrics to compare | BIONn | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship RelationshipBIONnPeersSector | |
|---|---|---|---|---|
P/E Ratio | 2.1x | 11.3x | 9.4x | |
PEG Ratio | 0.01 | 0.13 | 0.03 | |
Price/Book | 0.9x | 0.8x | 1.0x | |
Price / LTM Sales | 2.7x | 1.8x | 2.9x | |
Upside (Analyst Target) | 13.1% | 21.0% | 17.3% | |
Fair Value Upside | Unlock | 8.8% | 2.2% | Unlock |
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the BB Biotech (Xetra: BIONn) Share Price Today?
The BB Biotech stock price today is 55.800 EUR.
What Stock Exchange Does BB Biotech (BIONn) Trade On?
BB Biotech is listed and trades on the Frankfurt Stock Exchange.
What Is the Ticker (Stock Symbol) for BB Biotech?
The stock symbol (also called a 'ticker') for BB Biotech is "BIONn."
Does BB Biotech Pay Dividends? What’s The Current BIONn Dividend Yield?
Yes, BIONn Pays Dividends to its Shareholders. The current BB Biotech dividend yield is 4.48%.
What Is the Current BB Biotech Market Capitalisation?
As of today, BB Biotech (Xetra: BIONn) market cap is 3.070B EUR.
What Is BB Biotech's (BIONn) Earnings Per Share (TTM)?
The BB Biotech EPS is currently 24.490 (Trailing Twelve Months).
When Is the Next BB Biotech Earnings Date?
BB Biotech's next earnings report will be released on 23/10/2026.
Is BIONn a Buy or Sell From a Technical Analyst Perspective?
Based on today's BB Biotech moving averages and other technical indicators, the daily buy/sell signal for BIONn stock is Neutral.
How Many Times Has BB Biotech Stock Split?
BB Biotech has split 2 times. (See the BIONn stock split history page for full effective split date and price information.)
How Many Employees Does BB Biotech Have?
BB Biotech has 10 employees, based on their latest Companies House report.
What is the current trading status of BB Biotech (Xetra: BIONn)?
As of 23/09/2026, BB Biotech (BIONn) is trading at a share price of 55.800 EUR, with a previous close of 55.500 EUR. The stock has fluctuated within a day range of 55.600 EUR to 55.800 EUR, while its 52-week range spans from 37.650 EUR to 60.800 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.